Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in mice.
Endotoxin depresses cytochrome P450 levels when injected into animals. The purpose of this study was to determine whether endotoxin itself, or monokine(s) released in response to endotoxin administration are responsible for this effect. Cytochrome P450 levels and drug metabolizing activities were measured in endotoxin resistant C3H/HeJ mice 24h after single intraperitoneal injections of either lipopolysaccharide (LPS), a semipurified murine monokine preparation containing interleukin-1 (IL-1), or murine recombinant IL-1. In endotoxin sensitive C3H/HeN mice, LPS (0.5 mg/Kg) decreased total cytochrome P450 levels, benzphetamine demethylase activities, and ethoxyresorufin-0-deethylase activities. This dose of LPS did not alter cytochrome P450 levels or activities in the C3H/HeJ mice. However, after injection of the semipurified monokine preparation or the recombinant IL-1, there were significant decreases in cytochrome P450 levels and activities similar to the decreases observed with LPS in the C3H/HeN mice. These findings suggest that the alterations in hepatic cytochrome P450 seen with endotoxin injection are mediated, at least in part, by IL-1.
Shedlofsky
S I
SI
Swim
A T
AT
Robinson
J M
JM
Gallicchio
V S
VS
Cohen
D A
DA
McClain
C J
CJ
D000818:Animals; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D004731:Endotoxins / Q000494:pharmacology*; D004926:Escherichia coli; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008262:Macrophage Activation; D008297:Male; D051379:Mice; D015846:Monokines; D009929:Organ Size / Q000187:drug effects; D011506:Proteins / Q000494:pharmacology*
D004731:Endotoxins; D007166:Immunosuppressive Agents; D007375:Interleukin-1; D008070:Lipopolysaccharides; D015846:Monokines; D011506:Proteins; D003577:Cytochrome P-450 Enzyme System